Yu Heng

机构：University of Electronic Science and Technology of China, Chengdu Women's and Children's Central Hospital, Eye & ENT Hospital of Fudan University · ORCID：0000-0001-5625-8324

发表论文 81 篇 · 总被引 1051 次 · h-index 19

代表论文

• Camrelizumab-based induction chemoimmunotherapy in locally advanced stage hypopharyngeal carcinoma: phase II clinical trial (2024 · Nature Communications · 被引 24)
• Prolonged Survival of Neutrophils Induced by Tumor‐Derived G‐CSF/GM‐CSF Promotes Immunosuppression and Progression in Laryngeal Squamous Cell Carcinoma (2024 · Advanced Science · 被引 21)
• Automated diagnosis and management of follicular thyroid nodules based on the devised small-dataset interpretable foreground optimization network deep learning: a multicenter diagnostic study (2023 · International Journal of Surgery · 被引 17)
• High Expression of Tumor HLA-DR Predicts Better Prognosis and Response to Anti-PD-1 Therapy in Laryngeal Squamous Cell Carcinoma (2023 · Translational Oncology · 被引 16)
• Prognostic significance and immune escape implication of tumor-infiltrating neutrophil plasticity in human head and neck squamous cell carcinoma (2024 · Human Cell · 被引 5)
• Peripheral lymphocyte count as an indicator of radiotherapy effectiveness in hypopharyngeal squamous cell carcinoma (2024 · Clinical Otolaryngology · 被引 4)